Latent autoimmune diabetes - a diabetes mellitus 1,5 type?
- 作者: Khachaturyan N.E1,2
-
隶属关系:
- A.S.Loginov Moscow Clinical Scientific Practical Center of the Department of Health of Moscow
- A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
- 期: 卷 9, 编号 2 (2018)
- 页面: 31-35
- 栏目: Articles
- URL: https://ogarev-online.ru/2221-7185/article/view/45951
- DOI: https://doi.org/10.26442/2221-7185_2018.2.31-35
- ID: 45951
如何引用文章
全文:
详细
作者简介
N. Khachaturyan
A.S.Loginov Moscow Clinical Scientific Practical Center of the Department of Health of Moscow; A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
Email: nane18@list.ru
врач-эндокринолог; ст. лаборант каф. эндокринологии и диабетологии 111123, Russian Federation, Moscow, sh. Entuziastov, d. 86; 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
参考
- Глобальный доклад по диабету ВОЗ, 2016.
- Landin-Olsson M. Latent autoimmune diabetes in adults. Ann NY Acad Sci 2002; 958: 112-6.
- Leslie R.D, Williams R, Pozzilli P. Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J Clin Endocrinol Metab 2006; 91 (5): 1654-9.
- Tuomi T, Groop L, Zimmet P.Z, Merrill J et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42: 359-62.
- Tuomi T, Zimmet P, Mackay I.R et al. Latent Autoimmune Diabetes Mellitus in Adults (LADA): the Role of Antibodies to Glutamic Acid Decarboxylase in Diagnosis and Prediction of Insulin Dependency. Diabetes 1994; 11: 299-303.
- Zimmet P.Z. The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography. Diabetes Care 1995; 18: 1050-64.
- Fourlanos S, Perry C, Stein M.S et al. A clinical screening tool identifies autoimmune diabetes in adults. Diabetes Care 2006; 29 (5): 970-5.
- Behme M.T, Dupre J, Harris S.B et al. Insulin resistance in latent autoimmune diabetes of adulthood. Ann NY Acad Sci 2003; 1005: 374-7.
- Carlsson S, Midthjell K, Tesfamarian M.Y et al. Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trоndelag health study. Diabetologia 2007; 50 (1): 55-8.
- Nambam B, Aggarwal S, Jain A. Latent autoimmune diabetes in adults: A distinct but heterogeneous clinical entity. World J Diabetes 2010; 1 (4): 111-5.
- Thunander M, Thorgeirsson H, Törn C et al. b-cell function and metabolic control in latent autoimmune diabetes in adults with early insulin versus conventional treatment: a 3-year follow-up. Eur J Endocrinol 2011; 164 (2): 239-45.
- Maruyama T, Shimada A, Kanatsuka A et al. Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report. Ann N Y Acad Sci 2003; 1005: 362-9.
- Takino H, Yamasaki H, Sera Y et al. The preliminary report from the nation-wide prevention study for type 1 diabetes initially diagnosed as type 2 in Japan. Diabetes Metab Rev 1998; 14: 334-5.
- Kobayashi T, Nakanishi K, Murase T, Kosaka K. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 1996; 45: 622-6.
- Алгоритмы специализированной медицинской помощи больных сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. Вып. 8. М., 2017.
- Caswell M et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 3: 1-7.
补充文件
